Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2015 Jul;148(1):e31-e32.
doi: 10.1378/chest.15-0837.

Response

Affiliations
Free PMC article
Comment

Response

Jason Rho et al. Chest. .
Free PMC article

Comment on

Similar articles

  • Roflumilast in COPD.
    Worndl E, Hunt EB, Kennedy MP, Henry MT, Plant BJ, Murphy DM. Worndl E, et al. Chest. 2015 Jul;148(1):e31. doi: 10.1378/chest.15-0664. Chest. 2015. PMID: 26149563 No abstract available.
  • Rebuttal from Drs Suissa and Rabe.
    Suissa S, Rabe KF. Suissa S, et al. Chest. 2014 May;145(5):942-3. doi: 10.1378/chest.14-0113. Chest. 2014. PMID: 24798832 No abstract available.
  • Rebuttal from Dr Rho et al.
    Rho J, Ho N, Prasad V. Rho J, et al. Chest. 2014 May;145(5):943-4. doi: 10.1378/chest.14-0115. Chest. 2014. PMID: 24798833 Free PMC article. No abstract available.
  • [Clinical profile of roflumilast].
    Izquierdo Alonso JL. Izquierdo Alonso JL. Arch Bronconeumol. 2010 Dec;46 Suppl 10:25-32. doi: 10.1016/S0300-2896(10)70053-3. Arch Bronconeumol. 2010. PMID: 21316553 Review. Spanish.
  • [Phosphodiesterase-4 inhibitors: roflumilast].
    Izquierdo Alonso JL. Izquierdo Alonso JL. Rev Clin Esp. 2011 Mar;211 Suppl 2:22-30. doi: 10.1016/S0014-2565(11)70008-X. Rev Clin Esp. 2011. PMID: 21596170 Review. Spanish.
See all similar articles

MeSH terms

Feedback